According to rating firm ICRA, BE reported revenues of Rs 2,556.8 crore in FY22, largely driven by the government's Rs 1,500-crore contract order for supplying Corbevax vaccine against Covid.from Industry-Economic Times
Read The Rest:economictimes...
